As Hyperactivity Diagnoses Rise, Concerns Grow About Overmedication Of Children
New CDC data shows that nearly one in five boys have a medical diagnosis of attention deficit hyperactivity disorder. Other public health issues highlighted by news outlets include stroke risks in younger people, prescription-drug deaths and OSHA policies.
The New York Times: More Diagnoses Of Hyperactivity In New C.D.C. Data
Nearly one in five high school age boys in the United States and 11 percent of school-age children over all have received a medical diagnosis of attention deficit hyperactivity disorder, according to new data from the federal Centers for Disease Control and Prevention. These rates reflect a marked rise over the last decade and could fuel growing concern among many doctors that the A.D.H.D. diagnosis and its medication are overused in American children (Schwarz and Cohen, 3/31).
NPR: As Stroke Risk Rises Among Younger Adults, So Does Early Death
Most people (including a lot of doctors) think of a stroke as something that happens to old people. But the rate is increasing among those in their 50s, 40s and even younger (Knox, 4/1).
Los Angeles Times: Prescription Drug-Related Deaths Continue To Rise In U.S.
Despite efforts by law enforcement and public health officials to curb prescription drug abuse, drug-related deaths in the United States have continued to rise, the latest data show. Figures from the U.S. Centers for Disease Control and Prevention reveal that drug fatalities increased 3% in 2010, the most recent year for which complete data are available. Preliminary data for 2011 indicate the trend has continued (Glover and Girion, 3/29).
The New York Times: As OSHA Emphasizes Safety, Long-Term Health Risks Fester
OSHA, the watchdog agency that many Americans love to hate and industry often faults as overzealous, has largely ignored long-term threats. Partly out of pragmatism, the agency created by President Richard M. Nixon to give greater attention to health issues has largely done the opposite. OSHA devotes most of its budget and attention to responding to here-and-now dangers rather than preventing the silent, slow killers that, in the end, take far more lives. Over the past four decades, the agency has written new standards with exposure limits for 16 of the most deadly workplace hazards, including lead, asbestos and arsenic. But for the tens of thousands of other dangerous substances American workers handle each day, employers are largely left to decide what exposure level is safe (Urbina, 3/30).